ホーム > 市場調査レポート > 医療機器

表紙：エレクトロシューティカルズの世界市場：規模、シェア、成長分析、製品別、エンドユーザー別、タイプ別、業界予測（2022年～2028年）

市場調査レポート

商品コード

1244250

エレクトロシューティカルズの世界市場：規模、シェア、成長分析、製品別、エンドユーザー別、タイプ別、業界予測（2022年～2028年）

Global Electroceuticals Market Size, Share, Growth Analysis, By Product(Defibrillators, Pacemaker), By End-User(Hospitals & Clinics, Homecare & Others), By Type(Implantable Electroceutical, Non-Invasive Electroceutical) - Industry Forecast 2022-2028

出版日: 2022年10月16日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 826,535円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 966,890円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,107,245円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.95円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のエレクトロシューティカルズの市場規模は、2021年に168億米ドルとなりました。同市場は、予測期間（2022年～2028年）に5.0%のCAGRで拡大し、2028年には236億4,000万米ドルに達すると予測されています。

当レポートは、世界のエレクトロシューティカルズ市場について調査し、市場の概要とともに、製品別、エンドユーザー別、タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

主な企業プロファイル
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories, Inc.
LivaNova PLC
MicroPort Scientific Corporation
Sonova Group
Nevro Corp.
NeuroPace, Inc.
BIOTRONIK
Medico S.p.A.
Nurotron Biotechnology Co. Ltd.
MED-EL
Aleva Neurotherapeutics SA
NeuroSigma, Inc. (US)
Bioinduction Ltd. (UK)
GiMer Medical (Taiwan)
BioControl Medical (Israel)
tVNS Technologies GmbH (Germany)

Product Code: SQSG35A2009

The Global Electroceuticals Market was valued at USD 16.80 Billion in 2021, and it is expected to reach a value of USD 23.64 Billion by 2028, at a CAGR of 5.0% over the forecast period (2022 - 2028).

Medical technology has advanced quickly over the last few years, changing treatments and medicine. The market for electroceuticals has expanded tremendously as a result. The market for electroceuticals is expected to grow quickly during the projected period as a result of the healthcare industry's expansion and the widespread use of technology in medical applications.

The ageing of the population, the high prevalence of chronic diseases, the rapid improvements in medical technology, and the growing acceptance of alternative medicine are all expected to have a positive effect on market growth during the next four years. Because less invasive procedures are becoming more popular, it is predicted that demand for non-invasive electroceutical devices will surpass that for implantable electroceutical devices. However, it is projected that during the projection period the key difficulties that could restrict the potential of the electroceuticals market would be stringent regulatory standards, frequent product recalls, protracted approval procedures, and expensive costs.

During the course of the anticipated period, it is anticipated that the increasing prevalence of cardiovascular diseases will fuel market expansion for electroceuticals. In the upcoming years, it is anticipated that more cardiovascular diseases will be treated with electroceuticals. Implantable cardioverter defibrillators are expected to be in high demand during the projected period.

The recent decades have seen an upsurge in the prevalence of infectious and chronic diseases worldwide. As a result, both the demand for novel cures and the necessity for more research and development in the healthcare field have risen. The market potential for electroceuticals is expected to increase over the next four years as governments launch initiatives and provide funding to advance research and development.

Top-down and bottom-up approaches were used to estimate and validate the size of Asia Pacific Electroceuticals Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

Global Electroceuticals Market is segmented based on Product, End-User, type and region. Based on the product, the Global Electroceuticals Market is segmented into Defibrillators and Pacemaker, Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators, Hearing Aids and Cochlear Implants, and Others. Based on the end-user, the Global Electroceuticals Market is segmented into Hospitals & Clinics and Homecare & Others. By type, it is segmented into Implantable Electroceutical, Non-Invasive Electroceutical. Based on the region, the Global Electroceuticals Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

The increased incidence of cardiovascular diseases is one of the main factors boosting the worldwide electroceuticals market. It is believed that cardiovascular diseases are one of the main causes of death worldwide. More than 17.3 million people die from cardiovascular disease each year, according to the World Health Organization. Additionally, 23.6 million fatalities worldwide are anticipated to result from cardiovascular diseases by 2030. 31% of people worldwide suffer from cardiovascular diseases, and low- and middle-income countries account for 80% of all fatalities. Around 800,000 Americans died in the United States from cardiovascular disease, according to the American Heart Society. This opens up a lot of potential for the global electroceuticals market to expand during the forecast period. Moreover, substantial product releases by the leading market players are thought to be another important factor that will fuel the expansion of the worldwide electroceuticals market in the years to come.

Restraint

One of the main challenges the industry faces is a lack of public awareness regarding the usage of electroceutical devices in low- and middle-income nations. The use of implantable heart rhythm management systems and other electroceutical devices is common in high-income economies. Access is restricted in low- and middle-income (LMIC) nations. According to an American Heart Association study, Latin Americans residing in the US were less knowledgeable about AEDs and how to use them. The use of a defibrillator can significantly increase the chance of survival following cardiac arrest, yet because of a lack of public knowledge, a patient may go without care.

Market Trends

There are several market participants in the worldwide electroceuticals industry. The market's major manufacturers provide a wide range of electroceuticals for the treatment of illnesses. The prominent players functioning in the global electroceutical market include Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (the US), LivaNova PLC (UK), Cochlear Ltd. (Australia), MicroPort Scientific Corporation (China), Sonova Group (Switzerland), Nevro Corp. (US), BIOTRONIK (Germany), NeuroSigma, Inc. (the US), BioControl Medical (Israel), and tVNS Technologies GmbH (Germany) among many others.

Throughout the projected period, these companies will continue to fuel market expansion by implementing a variety of growth strategies, including product launches, mergers and acquisitions, joint ventures, and technological breakthroughs and developments. In March 2021, Medtronic plc (Ireland) got US FDA approval for its Intellis Platform with Differential Target Multiplexed (DTM) programming to treat chronic intractable back and leg pain, among other recent operations by the business in the electroceutical sector. While the Vercise Genus Deep Brain Stimulation System from Boston Scientific Company (US) was given US FDA certification in January 2021.

Executive Summary

Market Overview
Wheel of Fortune
Research Methodology
Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition
Market Dynamics & Outlook
Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Regulatory Landscape
Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Electroceuticals Market by Product
Market Overview
Defibrillators
Pacemaker
Deep Brain Stimulators
Spinal Cord Stimulators
Vagus Nerve Stimulators
Hearing Aids
Cochlear Implants
Others
Global Electroceuticals Market by End-User
Market Overview
Hospitals & Clinics
Homecare & Others

Global Electroceuticals Market by Type

Market Overview
Implantable Electroceutical
Non-Invasive Electroceutical
Global Electroceuticals Market Size by Region
Market Overview
North America
USA
Canada
Europe
Germany
Spain
France
UK
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
By Development
By Company
By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021
Key Company Profiles
Medtronic plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Boston Scientific Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Abbott Laboratories, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
LivaNova PLC (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Cochlear Ltd. (Australia)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
MicroPort Scientific Corporation (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Sonova Group (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Nevro Corp. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
NeuroPace, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
BIOTRONIK (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Medico S.p.A. (Italy)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Nurotron Biotechnology Co. Ltd. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
MED-EL (Austria)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Aleva Neurotherapeutics SA (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
NeuroSigma, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bioinduction Ltd. (UK)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
GiMer Medical (Taiwan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
BioControl Medical (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
tVNS Technologies GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments

ライセンス / 価格

PDF & Excel (Single User License)

USD 5,300 826,535円

PDF & Excel (Multiple User License)

USD 6,200 966,890円

PDF & Excel (Enterprise License)

USD 7,100 1,107,245円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.95円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

電気薬学

エレクトロシューティカルズの世界市場：規模、シェア、成長分析、製品別、エンドユーザー別、タイプ別、業界予測（2022年～2028年）

Global Electroceuticals Market Size, Share, Growth Analysis, By Product(Defibrillators, Pacemaker), By End-User(Hospitals & Clinics, Homecare & Others), By Type(Implantable Electroceutical, Non-Invasive Electroceutical) - Industry Forecast 2022-2028

目次

エグゼクティブサマリー

市場概要

親市場分析

市場規模

主要な市場の洞察

市場力学

世界のエレクトロシューティカルズ市場、製品別

世界のエレクトロシューティカルズ市場、エンドユーザー別

世界のエレクトロシューティカルズ市場、タイプ別

競合情勢

Table of Contents

Executive Summary

Parent Market Analysis

Global Electroceuticals Market by Type